Published on Microbicide Trials Network (http://www.mtnstopshiv.org)

Home > MTN-003B

MTN-003B

Details
Protocol Title: 
Bone Mineral Density Substudy
DAIDS Protocol ID: 
10709
Status: 
Closed to Accrual

Protocol Chair(s)

Sharon Riddler [1] (Protocol Chair)

Email Groups

MTN-003B Protocol Team [2]
MTN-003B Study Management Team [3]
Sites
Makerere University - Johns Hopkins University Research Collaboration [4]
Seke South Clinical Research Site [5]
Spilhaus Clinical Research Site [6]
Zengeza 3 Clinic [7]
Countries
Uganda [8]
Zimbabwe [9]
Description
Phase 2B Safety and Effectiveness Study of Tenofovir 1% Gel, Tenofovir Disoproxil Fumarate Tablet and Emtricitabine-Tenofovir Disoproxil Fumarate Tablet for the Prevention of HIV Infection in Women

The Bone Mineral Density Substudy is an observational study in a subset of participants in the VOICE study to explore the effects of oral study products on bone mineral density.

Other Study Info
Sponsors:
Division of AIDS (DAIDS)/NIAID/NIH
 
Co-Sponsors:
Gilead Sciences, Inc.
 
Study Design:
Observational substudy of VOICE
Printer-friendly version [10]
Source URL: http://www.mtnstopshiv.org/studies/1415

Links:
[1] http://www.mtnstopshiv.org/users/sriddler
[2] http://www.mtnstopshiv.org/people/emailgroups/127
[3] http://www.mtnstopshiv.org/people/emailgroups/120
[4] http://www.mtnstopshiv.org/sites/60
[5] http://www.mtnstopshiv.org/sites/73
[6] http://www.mtnstopshiv.org/sites/74
[7] http://www.mtnstopshiv.org/sites/739
[8] http://www.mtnstopshiv.org/countries/uganda
[9] http://www.mtnstopshiv.org/countries/zimbabwe
[10] http://www.mtnstopshiv.org/print/1415

Media Contacts:

Lisa Rossi -- Office: +1 412 641-8940 -- Mobile: +1 412 916-3315 -- Email: rossil@upmc.edu

Clare Collins -- Office: +1 412 641-7299 -- Mobile: +1 412 770-8643 -- Email: collcx@upmc.edu